Definitive Contract 75N91026C00004
Award Date 6/1/26
Potential Completion Date 5/31/31
Potential Value $9.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Competitive 8(a)
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
MONTGOMRY VLG, MD 20877, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $7,860,463 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to DAS Federal LLC, a small, woman-owned business, to provide operation and support services for the Cancer Therapy Evaluation Program's (CTEP) Protocol Information Office (PIO). The contract has a base period of one year and four option years, with a total potential period of performance through May 2026. This contract was awarded under a competitive...
- The National Cancer Institute awarded a definitive contract to EDJ Associates, Inc., a woman-owned small business, for support services to the Cancer Therapy Evaluation Program Pharmaceutical Management Branch on May 1, 2017, with a ceiling value of $8,958,021.76 under cost-plus-fixed-fee pricing. The originating solicitation was posted as a woman-owned small business set-aside on March 18, 2022, with performance based in Rockville, MD. The contract reached its ultimate completion date of June...
- <p>The National Cancer Institute awarded a $3.95 million definitive contract to Twotech Inc. for development support for the Office of Extramural Finance and Information Analysis on March 1, 2023, under an 8(a) sole source set-aside.</p> <p>Twotech Inc. is an 8(a) and EDWOSB certified small business. Place of performance is Rockville, MD. The contract carries a firm fixed price structure and an ultimate completion date of September 15, 2027.</p>
- <p>The National Cancer Institute issued a delivery order to the Institute for Defense Analyses on March 16, 2011, with a ceiling value of $199,248.25, to provide Cancer Therapy Evaluation Program (CTEP) funding for the Cooperative Groups transformation contract. Place of performance is Alexandria, VA. The order is structured as cost-plus-fixed-fee and has an ultimate completion date of September 30, 2012.</p>
- This is a $150,914,306.15 cost-plus-award-fee contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Ctis, Inc., a woman-owned small business. The purpose of the contract is to develop, maintain, and expand the existing Cancer Therapy Evaluation Program - Enterprise Information System (CTEP-ESYS) to support the NCI research community and migrate toward future NCI-wide enterprise development initiatives and the Cancer...
- The National Cancer Institute awarded a $111.9 million definitive contract to Technical Resources International, Inc., a minority-owned, woman-owned, and Hispanic American-owned small business, for drug development support for the Cancer Therapy Evaluation Program on July 1, 2022, under a cost-plus-fixed-fee pricing structure with no set-aside. The originating solicitation, posted May 11, 2021, sought capability statements for services including FDA submission preparation, adverse event...
- <p>The National Cancer Institute awarded a definitive contract to CCS Associates, Inc., a woman-owned small business, for regulatory support for cancer prevention agent development on September 30, 2011, under a total small business set-aside.</p> <p>The contract carries a ceiling value of $14,612,856.23 on a cost-plus-fixed-fee basis. Place of performance is San Jose, California. The ultimate completion date is September 29, 2018.</p>
- The National Cancer Institute awarded a $30.2 million cost-plus-fixed-fee contract to Asrc Federal Technology Solutions, LLC, an Alaska Native Corporation-owned 8(a) small disadvantaged business, to provide central support services to the National Cancer Institute's Center for Cancer Research through January 14, 2028. The contract, which commenced on January 15, 2023, encompasses a competitive 8(a) set-aside and will be performed in Bethesda, Maryland. In support of the contract's...
- The National Cancer Institute (NCI), a civilian agency, awarded a $3,202,752.76 cost-plus-fixed-fee definitive contract to Cabezon Group, Inc., an 8(a) sole source, minority-owned, self-certified small disadvantaged business, and veteran-owned company. The contract is for support services for the Division of Cancer Prevention (DCP) and has an ultimate completion date of April 22, 2015. Cabezon Group, Inc. has been awarded other federal contracts, including subcontracts, most recently on...
- This is a $9,994,470.76 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to ICF Esac, LLC, a small business, to serve as the Data Coordinating Center (DCC) for the Clinical Proteomics Tumor Analysis Consortium (CPTAC). The contract has an ultimate completion date of September 25, 2021. As the CPTAC DCC, ICF Esac is responsible for coordinating data management, analysis, and dissemination to support NCI's clinical proteomics research program focused on understanding the...